BioSpace News Archive

Record Fourth Quarter Total Revenue, Gross Margin, Net Income and Operating Cash Flow Full-Year 2021 Total Revenue Expected to Grow 30%-32% to Approximately $161 to $164 Million Conference Call Today at 8:30am Eastern Time

Centene Corporation (NYSE: CNC) announced today it will present at two upcoming virtual healthcare conferences in March. At the Barclays Global Healthcare Conference, to be held March 9-11, 2021 , Centene will participate in a virtual format on Tuesday, March 9 th at 9:10 a.m. Eastern Standard Time (EST).

Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will participate in the following virtual investor events: The Cowen 41 st Annual Health Care Conference on Wednesday, March 3, 2021

Amyris, Inc. announced that its Pipette® clean baby care brand will expand its brick and mortar retail presence in more than 600 Target stores across North America beginning in March 2021.

Academia-Industry Partnership to Support Improvements in UST Applications and Allow Global Food Companies Access to UST for Preparation of Safer, More Nutritious Liquid Foods and Beverages [24-February-2021] SOUTH EASTON, Mass. , Feb. 24, 2021 /PRNewswire/ --Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broa

Seven Bridges, the industry-leading bioinformatics ecosystem provider, is supporting Pfizer Inc. (NYSE: PFE) in the development of a data management and collaboration solution for the biopharmaceutical company’s single-cell ribonucleic acid (RNA) sequencing (scRNASeq) data

The FDA-authorized, saliva-based COVID-19 RT-PCR test expands testing access with a comfortable, at-home alternative - eliminating in-person waits and reducing exposure risk

Dascena, Inc., a machine learning diagnostic algorithm company that is targeting early disease intervention to improve patient care outcomes, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to the company’s GI Bleed Risk Alert System (Gibras).

Seagen to Present at the Cowen 41 st Annual Healthcare Conference

- Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D. join as advisors to help guide the company’s immunological cell therapy research efforts -